Recombinant hirudin for cardiopulmonary bypass anticoagulation: A randomized, prospective, and heparin-controlled pilot study

Thoracic and Cardiovascular Surgeon

Volumn 55, Issue 4, 2007, Pages 233-238

  Riess, Friedrich Christian ^a   Poetzsch, B ^c   Madlener, K ^b   Cramer, E ^a   Doll, K N ^a,e   Doll, S ^a,e   Lorke, D E ^d   Kormann, J ^a   Mueller Berghaus, G ^b  

^a ALBERTINEN KRANKENHAUS   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Anticoagulation; Cardiopulmonary bypass; Coronary bypass surgery; Heparin; Hirudin

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; ECARIN; HEPARIN; LEPIRUDIN; PROTAMINE; RECOMBINANT HIRUDIN; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; RECOMBINANT PROTEIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; GENE MUTATION; HUMAN; LUNG EMBOLISM; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; ANTICOAGULANT THERAPY; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; INTRAOPERATIVE PERIOD; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE;

ANTICOAGULANTS; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; INTRAOPERATIVE PERIOD; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS;

EID: 34447290011     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-955956     Document Type: Article

References (22)

1. Edmunds LH Jr. Blood-surface interactions during cardiopulmonary bypass. J Cardiovasc Surg 1993; 8: 404-410
2. Slaughter TF, LeBleu TH, Douglas JM Jr et al. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 1994; 80: 520-526
3. Bauer TL, Arepally G, Konkle BA et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circul 1997; 95: 1242-1246
4. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76: 638-648
5. Butterworth J, Lin YA, Prielipp RC et al. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg 2002; 74: 1589-1595
6. Poetzsch B, Madlener K. Management of cardiopulmonary bypass anticoagulation in patients with heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A (eds). Heparin-induced Thrombcytopenia. New York, NY: Marcel Dekker, 2004: 531-551
7. Greinacher A. Lepirudin for the treatment of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A (eds). Heparin-induced Thrombocytopenia. New York: Marcel Dekker, 2004: 397-436
8. Walenga JM, Bakhos M, Messmore HL et al. Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model. Blood Coagul Fibrinolysis 1991; 2: 105-111
9. Riess FC, Pötzsch B, Behr I et al. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model. Eur J Cardio-Thorac Surg 1997; 11: 739-745
10. Pötzsch B, Iversen S, Riess FC, Tzanova N, Seelig C, Nowak G, Müller-Berghaus G. Recombinant hirudin as an anticoagulant in open-heart surgery: a case report [abstr]. Ann Hematol 1993; 68 (Suppl 2): A46
11. Riess FC, Löwer C, Seelig C et al. Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man. J Thorac Cardiovasc Surg 1995; 110: 265-267
12. Riess FC, Pötzsch B, Bader R et al. A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open-heart surgery. Eur J Cardio-Thorac Surg 1996; 10: 386-388
13. Riess FC, Poetzsch B, Mueller-Berghaus G. Recombinant hirudin as an anticoagulant during cardiac surgery. In: Pifarré R (ed). New Anticoagulants for the Cardiovascular Patient. Philadelphia: Hanley & Belfus, 1997: 197-221
14. Koster A, Hansen R, Kuppe H et al. Recombinant hirudin as an alternative anticoagulant during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients. Cardiothorac Vasc Anesth 2000; 14: 243-248
15. Koster A, Pasic M, Bauer M et al. Hirudin as anticoagulant for cardiopulmonary bypass: importance of preoperative renal function. Ann Thorac Surg 2000; 69: 37-41
16. Longrois D, de Maistre E, Bischoff N, Dopff C, Meistelman C, Angioi M, Lecompte T. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia. Can J Anaesth 2000; 47: 255-260
17. Pötzsch B, Madlener K, Seelig C et al. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass-assessment of the whole blood ecarin clotting time. Thromb Haemost 1997; 77: 920-925
18. Chaitman BR, Alderman EL, Sheffield LT, Tong T, Fisher L, Mock MB, Weins RD, Kaiser GC, Roitman D, Berger R, Gersh B, Schaff H, Bourassa MG, Killip T. Use of survival analysis to determine the clinical significance of new Q. waves after coronary bypass surgery. Circul 1983; 67: 302-311
19. Oberman A, Kouchoukos NT, Makar YN, Russell RO Jr, Sheffield LT, Ray M, Allen RE, Kitts JR. Perioperative myocardial infarction after coronary bypass surgery. Cleve Clin Q 1978; 45: 172-81
20. Riess FC, Pötzsch B, Jäger K, Bleese N, Schaper W, Müller-Berghaus. Elimination von rekombinantem Hirudin aus der Blutzirkulation mittels Hämofiltration. Untersuchungen im Schweinemodell. Haemost 1997; 17: 200-204
21. Josa M, Siouffi SY, Silvermann AB, Barsamian EM, Khuri SF, Sharma GV. Pulmonary embolism after cardiac surgery. J Am Coll Cardiol 1993; 15: 990-996
22. Rastan AJ, Gummert JF, Lachmann N, Walther T, Schmitt DV, Falk V, Doll N, Caffier R, Richter MM, Wittekind C, Mohr FW. Significant value of autopsy for quality management in cardiac surgery. J Thorac Cardiovasc Surg 2005; 129: 1292-1300